Timothy P. Kelly - Jan 8, 2024 Form 4 Insider Report for Caribou Biosciences, Inc. (CRBU)

Role
Chief Technology Officer
Signature
/s/ Barbara G. McClung, attorney-in-fact
Stock symbol
CRBU
Transactions as of
Jan 8, 2024
Transactions value $
$0
Form type
4
Date filed
1/9/2024, 04:10 PM
Previous filing
Jan 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBU Option to purchase Common Stock Award $0 +300K $0.00 300K Jan 8, 2024 Common Stock 300K $5.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option shall vest on January 1, 2025, and the remaining shares subject to the option shall vest monthly thereafter (1/48 of the shares per month for the 36 months following the one-year cliff), subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.